1. SABAs as Reliever Medications in Asthma Management: Evidence-Based Science

   • Israel Amirav
   • Gabriel Garcia
   • Thitiwat Sriprasart

   Commentary Open access 07 June 2023 Pages: 2927 - 2943

   

2. Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review

   • Stephanie Korn
   • Bill Cook
   • Christopher S. Ambrose

   Review Open access 26 May 2023 Pages: 2944 - 2964

   

3. Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit

   • Yousef Al Saleh
   • Noor Al Busaidi
   • Guido Grassi

   Review Open access 26 May 2023 Pages: 2965 - 2984

   

4. A Critical Appraisal of Matching-Adjusted Indirect Comparisons in Spinal Muscular Atrophy

   • Tammy Jiang
   • Bora Youn
   • Nicole B. Johnson

   Review Open access 05 June 2023 Pages: 2985 - 3005

   

5. An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting

   • Rafael Bañares
   • Agustín Albillos
   • William Green

   Original Research Open access 09 May 2023 Pages: 3006 - 3020

   

6. Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study

   • Claudia Giofrè
   • Gabriella Fabbrocini
   • DARWIN study group

   Original Research Open access 12 May 2023 Pages: 3021 - 3037

   

7. Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States

   • Shujing Zhang
   • Arielle G. Bensimon
   • Clemens Krepler

   Original Research Open access 16 May 2023 Pages: 3038 - 3055

   

8. Indirect Costs Due to Lung Cancer-Related Premature Mortality in Four European Countries

   • Goran Bencina
   • Nour Chami
   • Ingel Demedts

   Original Research Open access 17 May 2023 Pages: 3056 - 3069

   

9. Design Development of the SMARTCLIC^®/CLICWISE^® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies

   • Kyle Berman
   • Simon Moss
   • Attila Antalfy

   Original Research Open access 18 May 2023 Pages: 3070 - 3086

   

10. Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison

    • Josep-Maria Ribera
    • Thibaud Prawitz
    • Petros Patos

    Original Research Open access 19 May 2023 Pages: 3087 - 3103

    

11. Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis

    • Kelly R. Reveles
    • Min Yang
    • Erik R. Dubberke

    Original Research Open access 21 May 2023 Pages: 3104 - 3134

    

12. Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

    • Cliff Molife
    • Katherine B. Winfree
    • Tarun Puri

    Original Research Open access 23 May 2023 Pages: 3135 - 3168

    

13. Abdominopelvic Surgery: Intraoperative Ureteral Injury and Prophylaxis in the United States, 2015–2019

    • Steven McCarus
    • Ana Filipa Alexandre
    • Steven D. Wexner

    Original Research Open access 25 May 2023 Pages: 3169 - 3185

    

14. Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study

    • Qian Zhao
    • Hongzhong Liu
    • Pei Hu

    Original Research Open access 26 May 2023 Pages: 3186 - 3198

    

15. Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment

    • Anne Marie Morse
    • Lois Krahn
    • Jennifer Gudeman

    Original Research Open access 27 May 2023 Pages: 3199 - 3216

    

16. Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy

    • Rudolph M. Navari
    • Winnie W. Nelson
    • William L. Bailey

    Original Research Open access 28 May 2023 Pages: 3217 - 3226

    

17. Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations

    • Rakesh K. Sahay
    • Richa Giri
    • Sadhna J. Joglekar

    Original Research 31 May 2023 Pages: 3227 - 3246

    

18. Surgery on Metastatic Foci is a Better Strategy for Stage IV Breast Cancer Patients with only Nonregional Lymph Node Metastasis

    • Yile Jiao
    • Xinyi Guo
    • Qing Lv

    Original Research 03 June 2023 Pages: 3247 - 3262

    

19. EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS

    • Roland Buhl
    • Michael Dreher
    • Claus F. Vogelmeier

    Brief Report Open access 31 May 2023 Pages: 3263 - 3278

    

20. Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study

    • Pierre-Dominique Ghislain
    • Jo Lambert
    • Siegfried Segaert

    Correction Open access 29 May 2023 Pages: 3279 - 3280